Description

Carbazochrome Sodium Sulfonate is a synthetic hemostatic agent that stabilizes capillary walls and reduces microvascular bleeding. It is commonly studied in laboratory models for its effectiveness in controlling internal hemorrhage, capillary permeability, and platelet-related responses.

Each box contains 30 tablets (2 blisters × 15 tablets), with 10mg of Carbazochrome Sodium Sulfonate per tablet. Manufactured by Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Branch, this product is NMPA-approved under H20053124.

?? This product is strictly intended for laboratory research purposes only. Not for human or veterinary use.

Specifications & Parameters

Potential Side Effects

While Carbazochrome Sodium Sulfonate is generally considered safe in controlled laboratory environments, research has shown that in certain models it may cause mild gastrointestinal discomfort, such as nausea or abdominal cramping. These effects are typically dose-dependent and should be carefully documented during experimental use.

Researchers are advised to monitor for any unexpected cellular responses or systemic effects when testing in biological models.

Mechanism & Research Applications

Carbazochrome Sodium Sulfonate is used in research to study its capillary-stabilizing effects, primarily by reducing vascular permeability and preventing microcapillary bleeding. It does not affect systemic coagulation but supports hemostasis by enhancing the integrity of the capillary wall.

Research Areas:

• Internal bleeding models

• Hemostasis and platelet aggregation

• Microvascular leakage studies

• Capillary permeability regulation

Disclaimer

This product is strictly for laboratory research purposes. It is not approved for clinical, diagnostic, or veterinary use. Handle in accordance with institutional safety protocols. Misuse may lead to regulatory or health risks.